Changes of oxyindole acetic acid excretion and the thrombocyte count under the influence of Zitofenton.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001792:Blood Platelets / Q000187:drug effects*; D001943:Breast Neoplasms / Q000188:drug therapy; D005260:Female; D006493:Heparin / Q000494:pharmacology; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007210:Indoleacetic Acids / Q000378:metabolism*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008297:Male; D008357:Mannomustine / Q000494:pharmacology*; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy; D014556:Urine
D007210:Indoleacetic Acids; D006493:Heparin; D008357:Mannomustine